Skip to content

Inventories at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$15.14B+12.9%
Stryker logo
StrykerSYK
$5.52B+4.4%
PDE
Pro-Dex, Inc.PDEX
$22.36M-4.6%
CONMED logo
CONMEDCNMD
$360.18M-0.6%
Vericel logo
VericelVCEL
$18.38M+9.2%
Anika Therapeutics logo
Anika TherapeuticsANIK
$28.57M+68.8%

Other financials

Income statement

See full
Revenue$2.1B+9.3%
Gross profit$1.5B+11.1%
Operating income$373.2M+27.7%
Net income$238.1M+30.8%
EPS (diluted)$1.22+34.1%

Balance sheet

See full
Cash & equivalents$424.2M-69.4%
Total debt$7.5B+4.1%
Total equity$12.7B+2.2%
Total assets$22.7B+2.4%

Cash flow

See full
Operating cash flow$359.4M-6.1%
CapEx$36.3M-18.6%
Free cash flow$323.1M-4.5%

Valuation

See full
Market cap$18.52B-1.4%
Enterprise value$25.57B-0.9%
P/E24.3×+1.5×
P/S2.2×-0.2×

Profitability

See full
Gross margin70%-1.0pp
Operating margin14%-3.0pp
Net margin9.1%-2.8pp
FCF margin17.3%-1.6pp

Returns & leverage

See full
Return on equity6.1%-1.2pp
Debt / equity0.6×0.0×
Current ratio1.7×-0.7×

Where this comes from

Reported directly by Zimmer Biomet Holdings in its filing.

Tagged under the XBRL concept us-gaap:InventoryNet.

The official record: Zimmer Biomet Holdings’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zimmer Biomet Holdings's inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zimmer Biomet Holdings's inventories?
Zimmer Biomet Holdings (ZBH) reported inventories of $2.25B in Q1 2026.
How has Zimmer Biomet Holdings's inventories changed year-over-year?
Zimmer Biomet Holdings's inventories increased by 0.1% year-over-year, from $2.24B to $2.25B.
What is the long-term trend for Zimmer Biomet Holdings's inventories?
Over 5 years (2020 to 2025), Zimmer Biomet Holdings's inventories has grown at a -1.4% compound annual growth rate (CAGR), from $2.45B to $2.29B.
What does inventories mean?
Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.